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Abstract
Background: Microglia are macrophage-like cells that constantly sense the microenvironment within the
central nervous system (CNS). In the event of neuronal stress or injury, microglial cells rapidly react and
change their phenotype. This response may lead to a deleterious type of microglial activation, which is
often associated with neuroinflammation and neurotoxicity in several neuropathological conditions. We
investigated the molecular mechanisms underlying triggering of microglial activation by necrotic neuronal
damage.
Methods: Primary cultures of microglia were used to study the effect of necrotic neurons on microglial
inflammatory responses and toxicity towards cerebellar granule neurons (CGN). The mouse hippocampal
cell line, HT22, was used in this study as the main source of necrotic neurons to stimulate microglia. To
identify the signal transduction pathways activated in microglia, primary microglial cultures were obtained
from mice deficient in Toll-like receptor (TLR) -2, -4, or in the TLR adapter protein MyD88.
Results: Necrotic neurons, but not other necrotic cell types, induced microglial activation which was
characterized by up-regulation of: i) MHC class II; ii) co-stimulatory molecules, i.e. CD40 and CD24; iii)
β2 integrin CD11b; iii) pro-inflammatory cytokines, i.e. interleukin 6 (IL-6), IL-12p40 and tumor-necrosis
factor (TNF); iv) pro-inflammatory enzymes such as nitric oxide synthase (iNOS, type II NOS),
indoleamine 2,3-dioxygenase (IDO) and cyclooxygenase-2 (COX-2) and increased microglial motility.
Moreover, microglia-conditioned medium (MCM) obtained from cultures of activated microglia showed
increased neurotoxicity mediated through the N-methyl-D-aspartate receptor (NMDAR). The activation
of microglia by necrotic neurons was shown to be dependent on the TLR-associated adapter molecule
myeloid differentiation primary response gene (MyD88). Furthermore, MyD88 mediated enhanced
neurotoxicity by activated microglia through up-regulation of the expression and activity of glutaminase,
an enzyme that produces glutamate, which is an NMDAR agonist.
Conclusion: These results show that necrotic neurons activate in microglia a MyD88-dependent pathway
responsible for a pro-inflammatory response that also leads to increased neurotoxic activity through
induction of glutaminase. This finding contributes to better understanding the mechanisms causing
increased neuroinflammation and microglial neurotoxicity in a neurodegenerative environment.
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Background
Necrotic-like neuronal death is associated with the devel-
opment of several pathologic conditions, including brain
ischemia subsequent to stroke or trauma [1], infectious-
driven neuroinflammation, e.g. meningitis [2], HIV-asso-
ciated dementia [3] and cerebral malaria [4], as well as
noninfectious-driven neuroinflammation, e.g. multiple
sclerosis (MS) [5]. In such pathological conditions micro-
glia, the resident CNS macrophage equivalents, may con-
tribute to neurotoxicity [6]. Upon neuronal injury,
microglial cells are activated, acquiring increased motility
and phagocytic activity. Moreover, expression of mole-
cules that regulate immune responses, including MHC
class I and II, FcγR, and the co-stimulatory molecules B7.1
and B7.2 are also increased during the process of micro-
glial activation. This can be beneficial by removing cellu-
lar debris and can also support neuronal survival through
the secretion of neurotrophic factors such as bFGF and
NGF (reviewed in [7]). On the other hand, this may also
lead to unfettered microglial activation with deleterious
consequences [8] such as increased production of the pro-
inflammatory cytokines IL-1β, TNF, IL-6 and IL-12 [9],
neurotoxins including the pro-oxidant molecules nitro-
gen oxide (NO) and reactive oxygen species (ROS) [10],
and metabolites such as quinolinic acid and glutamate
[11].
Specific factors released by stressed or damaged neurons,
including matrix metalloproteinase-3, (MMP-3), α-synu-
clein, neuromelanin [8], and ATP [12] have been shown
in vitro to induce the production of inflammatory factors
by microglia. On the other hand, during the last decade
several other putative endogenous "danger signals" or
"alarmins" [13], released by necrotic but not by apoptotic
cells have also been shown to stimulate pro-inflammatory
responses in dendritic cells and in monocytes/macro-
phages. These "danger signals" include the heat shock
proteins (hsp) hsp60, hsp70, hsp90, and gp96 [14]; the
calcium-binding S100 proteins [15], DNA, proteases, uric
acid and the chromosomal protein high-mobility group
B1 (HMGB1) (reviewed in [16]). These molecules,
referred to as "damage-associated molecular patterns"
[13], can be recognized by a series of pattern recognition
receptors (PRR) that include TLRs [17], the receptor for
advanced glycosylation end products (RAGE) [18] and
scavenger receptors [19], but also by other cell surface pro-
teins such as CD40 [20] and CD91 [21], and the intracel-
lular NOD-like receptors (NLRs) family as well, namely
NALP-3 [22].
Phenotypic alterations and migration of microglial cells
following neuronal cell damage have been extensively
reported. However, the molecular mechanisms mediating
this activation and microglial cell neurotoxicity require
further elucidation. Here we address the effects of neuro-
nal necrosis on microglial activation and neurotoxicity. In
this paper we report that necrotic neurons, but not other
necrotic cell types, can induce in microglia a pro-inflam-
matory phenotype that in turns causes NMDAR-mediated
toxicity of neurons. This activation of and neurotoxic
activity by microglia resulting from stimulation by
necrotic neurons is shown to be dependent on MyD88,
which mediates the up-regulation of glutaminase.
Methods
Mice
C57BL/6, B10scN (which lack the genomic region con-
taining the tlr-4  gene), TLR-2 (C57BL/6) and MyD88
(C57BL/6) deficient mice were bred and maintained
under specific pathogen-free conditions in our animal
facilities in accordance with guidelines from the Animal




Neonatal microglia cultures were prepared from newborn
mice as described previously [23]. Briefly, after removal of
the meninges, brains were mechanically disrupted. Cells
were cultured in high-glucose Dulbeco's Modified Eagle
Medium (DMEM) medium containing Glutamax (Invit-
rogen, Carlsbad, CA) and supplemented with 10% FBS
(Endotoxin less than 10 EU/ml, Invitrogen), 5 μg/ml insu-
lin (Sigma-Aldrich Química, S.A, Portugal), 2.0 mg/ml L-
glucose (Sigma) and 1% Penicillin-Streptomycin 50 mM
(Invitrogen) for 14–21 days (naïve microglia). Granulo-
cyte-macrophage colony-stimulating factor (GM-CSF)
(Peprotech, Rocky Hill, NJ) (GM-CSF-microglia) was
added at the beginning of the culture and subsequently
every 3 days at a final concentration of 0.25 ng/ml. At day
14, confluent mixed glial cell cultures were shaken for 3 h
at 250 rpm. Microglial cells were obtained from the super-
natant after filtering through 100-μm cell strainers (BD,
Becton, Dickinson and Company, Franklin Lakes, NJ).
Cells were resuspended in RPMI 1640 with Glutamax
(Invitrogen) supplemented with 5% FBS, 50 μM β-mer-
captoethanol and 1% Penicillin-Streptomycin (RMPI-
FBS). Cells were plated in 6 well plates (1 × 106) or 24 well
plates (2 × 105) for 1 hour. Adherent cells were washed
twice with warm Hanks balanced salt solution (HBSS) to
remove cell debris and astrocytes. The purity of the pri-
mary cultures assessed by CD11b staining and FACS anal-
ysis was >90%.
Astrocytes and cerebellar granule neurons
An enriched population of primary astrocytes was
obtained from the adherent cell population after shaking
the mixed cell brain cultures. Primary cerebellar granule
neurons (CGN) were prepared from 6-day-old mice as
described previously [24]. Briefly, cerebella were dissectedJournal of Neuroinflammation 2008, 5:43 http://www.jneuroinflammation.com/content/5/1/43
Page 3 of 12
(page number not for citation purposes)
and the cells were dissociated and plated at a density of 1
× 105 neurons/cm2 on poly-L-lysine (0.5 mg/ml, Sigma)
coated plates. Cells were maintained in Basal Medium
(BME) supplemented with 10% (v/v) FBS, 25 mM KCl
(Sigma), 1% penicillin-streptomycin, 1% glutamax and 6
mg/ml glucose. After 24 hr, the medium was replaced to
remove dead cells by the above culture medium supple-
mented with 1% (v/v) N-2 supplement and 50 μM cyto-
sine arabinoside (Sigma) to prevent proliferation of non
neuronal cells. Cultures were kept in an incubator at 37°C
in 5% CO2 and were used after 8 days.
Induction of cell death
The mouse hippocampal cell line HT22 (kindly provided
by J. Pocock) and WHEI 164 cells were cultured in DMEM
containing 10% FBS. EL-4 cells were cultured in complete
RPMI medium containing 10% FBS. All cell lines tested
negative for Mycoplasma by PCR. Cells were trypsinized
with Trypsin/EDTA (Invitrogen) and washed twice in
endotoxin-free PBS. Cells were resuspended in PBS (107
cells/ml) and a necrotic-like cell death type was induced
by 3 cycles of freeze and thaw or mechanically disrupted
using a syringe and needle (0.5 × 16 mm). Cells were
immediately added to microglial cells or kept on ice until
they were used to minimize protease activity. Loss of cell
viability was confirmed using trypan-blue (Sigma) (>95%
cell death). To induce apoptosis, cells were UV-irradiated
in a UV Stratalinker 2400 (Stratagene, La Jolla, CA) for 1
h. The percentage of apoptotic cells was assayed by FACS
analysis of annexin staining according to manufactures
instructions (BD Biosciences, Pharmingen™).
Cell stimulation
Primary cultures and cell lines were stimulated with
necrotic cells (1:1 or 50–100 μg/ml), IFN-γ (Peprotech)
(10–100 U/ml), LPS (Sigma) (100 ng/ml) or Pam3CSK4
(InvivoGen, San Diego, CA) (300 ng/ml) for 24 hours in
RPMI 1640 with Glutamax (Invitrogen) supplemented
with 5% FBS, 50 μM β-mercaptoethanol and 1% Penicil-
lin-Streptomycin (RMPI-FBS).
Migration Assay
Cell migration in studies of chemotaxis was assayed as
described previously [25]. Briefly, 500 μl of medium con-
taining ATP (100 μM), necrotic cells (2 × 105 or 50 μg/ml),
were applied to 24-well culture plates. Microglial cells (2
× 105) were plated in a 10 mm diameter tissue culture
insert with an 8 μm pore size polycarbonate membrane
(Nalgene Nunc, Roskilde, Denmark) placed into each
well. Cells were incubated for 3 hours at 37°C in 5% CO2
atmosphere and migrated cells were collected from the
lower chamber. After centrifugation cells were stained
with trypan-blue and counted using a hemocytometer
(Neubauer chamber) or mixed with 10 μm latex beads
(Bechman Coulter, Fullerton, CA) and counted by flow
cytometry (BD, FACSCalibur™)
Flow cytometry
Antibodies against CD11b (M1/70), CD11c (HL3), H-
2Kb (AF-88.5), CD86 (GL1), CD40 (3/23), CD80 (16-
10A1), CD14 (rmC5-3), CD45 (30-F11) and CD24 (M1/
69) were purchased from BD Biosciences (BD, Pharmin-
gen™). The antibody against FcγR (2.4G2) was prepared in
house from hybridoma culture supernatants. Microglial
cells were detached with cold PBS containing 0.5 mM
EDTA and incubated with anti-Fc receptor in FACS buffer
(PBS containing 2% FCS and 0.01% NaN3) for 30 min at
4°C before staining. After washing cells were incubated
with streptavidinallophycocyanin or phycoerythrin (BD,
Pharmingen™) for 20 min at 4°C to detect biotinylated
antibodies. Cells were then washed and acquired using
FACSCalibur™ and CELLQuest™ software (BD Becton,
Dickinson and Company). Post acquisition analysis was
done with CELLQuest™ or FlowJo™ (Tree Star, Ashland,
OR) software.
Neurotoxicity assay
CGN seeded in glass coverslips were incubated with MCM
from non-stimulated cultures or from microglia activated
with necrotic neurons at a final concentration of 20%.
Where indicated, the MCM was obtained from microglial
cells cultured in glutamine-free medium or in medium
containing 20 μM of iNOS inhibitor, L-N6-(1-Iminoe-
thyl) lysine (L-Nil, Tocris, UK); 1 mM of IDO inhibitor
(Sigma), 1-Mehyl-DL-tryptophan (1-MT, Sigma), or 1,5
mM of glutaminase inhibitor, 6-diazo-5-oxo-L-norleucine
(DON, Sigma). NMDA receptor antagonist, 10 μM MK-
801 (Tocris), was added to neurons at same time as MCM.
To quantify and assess neuronal cell survival, cells were
incubated with 10 μg/ml 4'-6'-Diamidino-2-phenylindole
(DAPI, Sigma) for 10 min at 37°C and 4 μg/ml propid-
ium iodide (PI, Sigma) for 2 min also at 37°C. PI positive
cells (~500) were counted in more than five fields per cov-
erslip and cell death was expressed as the percentage (%)
of PI positive cells from the total cells.
Analysis of cytokines, nitrites (NO2
-) and glutamate
Cytokines were quantified in the supernatant of microglia
cultured for 24 hours by ELISA according to manufac-
turer's instructions: TNF, IL-1β, IL-6 (R&D Systems, Min-
neapolis, MN) and IL-12 (p40 subunit) (BD OptEIA™).
The production of NO by iNOS was measured indirectly
by assaying nitrites in the culture supernatant using the
Griess reaction. Supernatants were mixed with an equal
volume of Griess reagent [26]. Optical density measure-
ments were averaged and converted to micromoles of
nitrites per well using a standard curve of sodium nitrite.
L-Glutamic acid concentration in the supernatants was
determined using the Amplex Red reagent-based assayJournal of Neuroinflammation 2008, 5:43 http://www.jneuroinflammation.com/content/5/1/43
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(Invitrogen) accordingly to the manufacturer's instruc-
tions.
Reverse transcription-PCR Analysis
Microglial cells were treated with IFN-γ (10 U/ml),
necrotic HT22 cells (1:1) or left untreated for 24 hours.
Total RNA was isolated from microglial cells using Trizol
(Invitrogen, USA). RNA was reverse-transcribed from 2 μg
of total RNA by 200 U of M-MuLV reverse transcriptase
(Fermentas, UK) used accordingly to manufacturer's
instructions. PCRs were performed with diluted cDNA
using primers for iNOS (sense: 5'-AAG CTG CAT GTG
ACA TCG ACC CGT-3'; antisense: 5'-GCA TCT GGT AGC
CAG CGT ACC GG-3'), COX-2 (sense: 5'-CAG CAC TTC
ACC CAT CAG TT-3'; antisense: 5'-CTG GTC AAT GGA
GGC CTT TG-3'), IDO (sense: 5'-GTA CAT CAC CAT GCT
GTA TG-3'; antisense: 5'-GCT TTC GTC AAG TCT TCA
TTG-3'), Glutaminase (sense: 5'-GTA ATG ATC GTC AAC
GGG GGA GGA C-3'; antisense: 5'-CCA GCA AGC CTT
GCA ACC TTA ACC TTA ACC A-3') and HPRT (sense: 5'-
GTA ATG ATC GTC AAC GGG GGA GGA C-3'; antisense:
5'-CCA GCA AGC TTG CAA CCT TA A CCT TAA CCA-3').
PCR products were resolved on 1% ethidium bromide-
stained agarose gel.
Statistical analysis
Data is expressed as mean ± SD and was analyzed for sig-
nificance using Student's t test. P-values are as follows:
*** p < 0.005, ** p < 0.01 and * p < 0.05.
Results
Activation of microglia by necrotic neurons
Neuronal cell injury has been previously shown to be
associated with up-regulation of several molecules
involved in immunological responses of microglia [7]. We
investigated the modulation of several cell activation
markers [7] by microglial cells responding to necrotic neu-
ronal HT22 cells, a mouse hippocampal cell line [27],
using FACS analysis (Figure 1A). Microglial cells
responded to necrotic HT22 cells with a 2–6 fold increase
in the expression of CD40 and of MHC class II (Figure
1A). The alpha chain of the αMβ2 integrin CD11b and the
heat-stable antigen CD24 were also increased, albeit to
lesser degrees (~2 fold, p < 0.05 and p < 0.001 respec-
tively) (Figure 1B). Other molecules such as the co-stimu-
latory molecules B7.1 and B7.2 and CD11c were not up-
regulated whereas CD45 and CD14 were poorly induced
by necrotic cells (Figure 1B). Apoptotic HT22 neuronal
cells induced a lower increase in CD40 expression in
microglial cells when compared to necrotic HT22 cells
(Figure 1B, right graph). However, some degree of stimu-
lation was detectable with apoptotic HT22 cells, which is
probably explained by the high percentage of secondary
necrosis which we observed during incubation with
microglia (40% after 24 hours) (data not shown). Primary
cerebellar granule neurons (CGN), but not astrocytes,
mimicked the effect of necrotic HT22 cells by inducing
CD40 expression (Figure 1C, left panel) and TNF secre-
tion by microglia (71.5 ± 17.6 pg/ml compared to non-
detectable values in non-stimulated microglia or micro-
glia incubated with astrocytes). In addition, necrotic cells
obtained from mouse EL-4 (lymphoma) or WHEI 164
(fibrosarcoma) cell lines were unable to trigger CD40
expression (Figure 1C, right panel) or TNF (non-detecta-
ble values) in microglia. We further evaluated the pro-
inflammatory phenotype of microglia upon stimulation
with necrotic neurons. Necrotic neurons induced 11- and
9-fold increases in secretion of IL-12p40 and IL-6, respec-
tively (Table 1). Production of TNF and of NO, estimated
by the nitrite concentration in the supernatant of micro-
glial cell cultures, were significantly increased by necrotic
neurons although ~10-fold lower when compared with
the levels induced by other stimuli such as IFN-γ or LPS
(data not shown). IL-1β was not induced in microglia by
necrotic neurons (Table 1). Furthermore, the mRNA
expression levels of enzymes induced during neuroin-
flammatory conditions triggered by infection or brain
injury, such as iNOS [28], IDO [29] and COX-2 [30], were
increased in microglia by necrotic neurons (Figure 1D).
Finally, necrotic neurons, when compared to a chemotac-
tic stimulus such as ATP [31], induced significantly greater
migration of microglial cells, (p < 0.01) seeded on a mem-
brane insert, towards a lower chamber containing necrotic
HT22 cells (Figure 1E). In summary, a clear pro-inflam-
matory phenotype is induced in microglia upon stimula-
tion with necrotic neurons, as is increased microglial
motility.
Microglial activation by necrotic neurons is MyD88-
dependent
There is mounting evidence suggesting that "danger sig-
nals" released from necrotic cells can be recognized by
PRR expressed on monocytes/macrophages and dendritic




IL-1β 36.6 ± 16.4 37.5 ± 10.3
TNF ND 15.2 ± 5.4*
IL-12p40 67.7 ± 5.8 745.7 ± 15.5***
IL-6 188.3 ± 4.3 1735.8 ± 85.2***
NO2
- (μM) ND 12.5 ± 1.6***
Microglial cells were left untreated or stimulated with necrotic HT22. 
IL-1β, TNFα, IL-12p40, IL-6 and NO2
- were assayed in the cell 
supernatant 24 hours after stimulation. ND, non-detectable. *** p < 
0.001 and * p < 0.05.Journal of Neuroinflammation 2008, 5:43 http://www.jneuroinflammation.com/content/5/1/43
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Figure 1 (see legend on next page)Journal of Neuroinflammation 2008, 5:43 http://www.jneuroinflammation.com/content/5/1/43
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cells. These PRR include, but are not restricted to, mem-
bers of the TLR family. MyD88 is an adapter protein
required for signal transduction by TLRs, with the excep-
tion of TLR-3 [32]. We isolated microglial cells from
MyD88-deficient mice to assess whether this pathway is
involved in signal transduction pathways via which
necrotic neurons activate microglial cells. Ablation of
MyD88 in microglia cells suppressed microglial activation
by necrotic neurons, as assessed by the expression of
CD40 or MHC class II (Figure 2A). MyD88-deficient
microglia could be activated by IFNγ but not by a specific
ligand for TLR-2, Pam3CSK4. Increased IL-6 or IL-12
secretion was also abolished in MyD88-deficient micro-
glia stimulated with necrotic neurons (Figure 2B). These
results demonstrate that necrotic neurons are most likely
recognized by PRRs expressed on microglia that signal via
MyD88 to induce expression of pro-inflammatory genes
associated with microglial activation.
TLR-2 and TLR-4 have been identified in macrophages
and dendritic cells as putative receptors for endogenous
signals such as heat shock proteins hsp70 and gp96 [17]
and the chromatin binding HMGB1 protein [33]. We eval-
uated the putative role of these two TLRs in the microglial
response to necrotic neurons using TLR-2-/-  mice and
B10ScN mice, which lack the genomic region containing
the tlr-4 gene (Figure 2C). Microglia derived from these
mouse lines maintained increased CD40 expression when
incubated with necrotic neurons (Figure 2C). These data
suggest that necrotic neurons contain ligands for My88-
dependent TLR signaling other than TLR-2 or TLR-4 or,
alternatively, suggest that several TLRs are activated and
interfering with TLR-2 or TLR-4 signaling alone does not
impair the microglial response.
Necrotic neurons enhance microglial glutamate-
dependent neurotoxicity
Microglial cells, depending on their activation phenotype,
secrete a variety of factors that include both neurotrophic
factors such as bFGF and NGF and neurotoxic metabolites
like NO and glutamate [11]. We assessed the neurotoxic-
ity of microglia-conditioned medium (MCM), added at
final concentration of 20%, obtained from untreated
microglia or from microglia activated with necrotic neu-
rons. Although MCM from untreated microglia exhibited
some neurotoxicity, probably due to basal activation lev-
els of this cell type [34], neuronal cell death was signifi-
cantly increased by 21.5% (p < 0.005) when neurons were
incubated with MCM from activated microglia (MCM
(Nec.), Figure 3A). The neurotoxicity of MCM was due to
the microglial conditioning since exposure of neurons to
fresh medium at the same ratio resulted in a lesser, and
non-significant, increase in cell death (13.4 ± 10.5% of
neurons compared to 8.3 ± 3.0% in the absence of
medium). We next investigated the basis for MCM-
induced neurotoxicity. This was neither abolished when
MCM was heat inactivated before exposing it to neurons,
nor by inhibition of the microglial enzymes iNOS and
IDO, which are responsible for the formation of two neu-
rotoxic agents, NO and QA, respectively (data not
shown). On the other hand, MCM obtained from micro-
glial cells cultured in glutamine-free medium (-
Glutamine) or in the presence of the glutaminase inhibi-
tor, DON (+ DON), showed significantly reduced neuro-
toxicity (Figure 3B). These results suggested that cell death
could be mediated by glutamate through NMDAR. To test
this hypothesis, MCM from non-stimulated or stimulated
microglia were added together with MK-801, an antago-
nist of NMDAR. In both conditions, the antagonist com-
pletely abolished the MCM-induced neurotoxicity, clearly
showing that the mechanism of neurotoxicity mediated
Necrotic neurons induce expression of activation markers by microglia Figure 1 (see previous page)
Necrotic neurons induce expression of activation markers by microglia. (A) Microglia were stimulated with necrotic 
HT22 neurons at a ratio of 1:1 for 24 hours and the expression of several activation markers analysed by FACS. The staining 
intensity is represented on histogram overlays for the mentioned proteins in non-stimulated microglia (grey filled), and in 
microglia stimulated either with IFN-γ (100 U/ml) (dashed line) or with necrotic neurons (solid line). (B) These results are 
shown as fold increases ("fold activation") of the Geo Mean when divided by the average expression of triplicates of untreated 
microglia. The fold increase in the expression of the different markers was compared to the effect on B7.1 expression. 
Necrotic neurons were significantly more efficient than apoptotic HT22 cells in inducing CD40 expression by microglia (graph 
on the right). (C) Histogram overlays for CD40 staining intensity of microglia cultured in medium only (grey filled), stimulated 
with necrotic HT22 neurons (solid line), or incubated with different necrotic cell types: histogram plot on the left, primary cer-
ebellar granule neurons (CGN) (dashed line), astrocyte-enriched cell population (dotted line); histogram plot on the right, EL-
4 (dotted line) and WHEI-164 (dashed line) cell lines. (D) Microglial cells were stimulated for 24 hours with necrotic neurons 
or with IFN-γ (10 U/ml), and the expression of COX-2, IDO and iNOS was analysed by RT-PCR. (E) Microglial cells were 
plated in an insert containing a membrane with a cut-off of 8 μm. The number of microglial cells migrated through the mem-
brane was quantified 3 hours after adding necrotic HT22 neurons (50 μg/ml) to the lower chamber. ATP (100 μM) was used as 
a positive control for chemotaxis. Data are representative of at least two experiments done in triplicate. *** p < 0.001; **p < 
0.01 and * p < 0.05.Journal of Neuroinflammation 2008, 5:43 http://www.jneuroinflammation.com/content/5/1/43
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Microglial response to necrotic neurons is MyD88-dependent Figure 2
Microglial response to necrotic neurons is MyD88-dependent. (A) Microglial cells derived from MyD88-deficient mice 
were stimulated with necrotic HT22 cells for 24 hours and the expression of CD40 and MHC class II was assessed and com-
pared to that of wild type cells. Pam3CSK4 is a TLR-2 ligand; ND, non-detectable. (B) The levels of IL-6 and IL-12 were quanti-
fied in the supernatants of microglial cell cultures by ELISA. (C) Induction of CD40 expression in TLR-2 or TLR-4 deficient 
microglia stimulated with necrotic neurons. LPS is a specific ligand for TLR-4. Results are shown as mean ± SD of three inde-
pendent experiments or are representative of at least two experiments. *** p < 0.001; **p < 0.01 and * p < 0.05.Journal of Neuroinflammation 2008, 5:43 http://www.jneuroinflammation.com/content/5/1/43
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Necrotic neurons enhance microglial-induced neurotoxicity mediated by NMDAR Figure 3
Necrotic neurons enhance microglial-induced neurotoxicity mediated by NMDAR. (A) Neurotoxicity of MCM was 
assayed in cell cultures of CGN after 24 hours. MCM obtained from non-stimulated cells or after stimulation with necrotic 
neurons for 20 hours, MCM (Nec.), were added to a final concentration of 20% to neuronal cultures. Neuronal viability was 
analysed by PI incorporation after 24 hours. (B) Neuronal cell death was quantified after exposure to MCM of non-stimulated 
cells, MCM of microglial cells cultured in glutamine-free medium, MCM (- Glutamine), or cultured with a glutaminase inhibitor, 
MCM (+DON). (C) The NMDAR inhibitor, MK-801, was added to neuronal cultures at the same time as MCM and neuronal 
viability was assayed as described before. Results are shown as mean ± SD and are representative of at least two experiments. 
NS, non-significant. *** p < 0.001 and * p < 0.05.Journal of Neuroinflammation 2008, 5:43 http://www.jneuroinflammation.com/content/5/1/43
Page 9 of 12
(page number not for citation purposes)
by microglia is NMDAR-dependent. Altogether these
results show that necrotic neurons cause an over-activa-
tion of microglia with consequent NMDAR-mediated
neurotoxicity, most likely mediated through increased
production of glutamate.
Deletion of MyD88 in microglia blocks up-regulation of 
glutaminase and neurotoxicity by necrotic neurons
As we have demonstrated above, necrotic neurons activate
microglia through a MyD88-dependent pathway. Conse-
quently, we investigated whether the enhanced neurotox-
icity of stimulated microglia was affected by the absence
of MyD88. In contrast to wild type microglia, the increase
in neurotoxicity associated with activation of microglia by
necrotic neurons was completely abrogated in the absence
of MyD88 expression in microglia (Fig 4A). When pri-
mary cerebellar neurons were cultured with 20% MCM
from microglia pre-stimulated with necrotic neurons
there was a 33% increase in cell death compared to cere-
bellar neurons cultured with MCM from non-stimulated
cultures. In contrast, MCM from MyD88-deficient micro-
glia treated with necrotic neurons did not show any
increase in neurotoxicity. Since we have shown (Figure 3)
that neurotoxicity is dependent on glutaminase activity,
we analysed the mRNA expression levels of glutaminase
and glutamate in supernatants of microglia from both
wild type and MyD88-deficient microglia. We observed
that the observed increase in neurotoxicity correlated with
up-regulation of glutaminase mRNA expression in wild
type microglia activated by necrotic neurons (Figure 4B).
This increase was not observed in MyD88-deficient micro-
glia, and this explains the inability of these microglia to
produce enhanced neurotoxicity upon stimulation with
necrotic neurons. Concomitantly, levels of glutamate
were increased in MCM of wild type, but not MyD88-defi-
cient, microglia stimulated with necrotic neurons 4C.
Taken together our results demonstrate that neurotoxicity
induced by necrotic neurons in microglia is mediated
through MyD88-dependent signaling cascades, leading to
increased glutaminase expression and consequent
increase in glutamate-mediated neurotoxicity.
Discussion
Microglia and perivascular macrophages/dendritic cells in
the CNS become activated upon neuronal injury. The goal
of the present study was to understand the pathways of
microglial activation induced by neuronal necrosis, and
the effects of such activation on microglia-mediated neu-
rotoxicity. We demonstrate that necrotic neurons induce
several markers of microglial activation such as co-stimu-
latory molecules, MHC class II, pro-inflammatory
cytokines and enzymes and enhanced motility. This acti-
vation, which involves a MyD88-dependent signalling
pathway, also increases NMDAR-dependent microglial
neurotoxicity by up-regulation of glutaminase expression
and activity.
Bacteria-derived products are known to induce neuronal
cell death through the activation of the MyD88 pathway
in microglia [35]. Here we demonstrate that "molecular
danger patterns" exposed by necrotic neurons also acti-
vate microglia and enhance microglial neurotoxicity by a
MyD88-dependent pathway. However, in the absence of
TLR-2, TLR-4 and TLR-9 (data not shown) which signal
through MyD88, the response of microglia to necrotic
neurons is not affected. Either necrotic neurons activate
other than those tested, or more than a single TLR are
redundantly activated in response to the necrotic stimuli.
In the later case, only by blocking a common signaling
point, as in MyD88-deficient microglia, would activation
of microglia by necrotic neurons be highly compromised
as we have observed using assays of CD40 and MHC II
expression and IL-6 and IL-12 production (Figure 3). A
mechanism involving activation of NLRs by ligands
exposed by necrotic neurons cannot be excluded since
these PRRs induce IL-1β and IL-18 which act through
MyD88. [36]. However, we did not detect an increase in
IL-1β secretion by microglia activated with necrotic neu-
rons.
Microglia activated with necrotic neurons clearly show a
pro-inflammatory phenotype dependent on MyD88. This
type of response by microglia may contribute to enhanced
neuropathogenesis after necrotic neuronal cell death.
Interestingly, it has been shown recently that MyD88-defi-
cient mice, but not TLR4/TLR2-deficient mice, show
reduced brain inflammatory responses and decreased
lesions after cold-induced cortical injury [37]. However,
pro-inflammatory mediators may have diverse effects
after neuronal injury caused by brain ischemia. Whereas
inhibition of COX-2 is neuroprotective [38], the role of
pro-inflammatory cytokines such IL-6 and TNF is ambig-
uous in this context, with both deleterious and beneficial
effects having been reported [39].
We have demonstrated that glutaminase expression is reg-
ulated by a MyD88-dependent pathway. By bioinformat-
ics analysis using PROMO software [40,41], we have
identified three putative DNA-binding sites for the tran-
scription factor Activation Protein-1 (AP-1) at 20 bp, 240
bp and 300 bp upstream of the start codon. Since a
MyD88-dependent pathway was shown to activate AP-1,
which together with NF-kB controls the induction of pro-
inflammatory cytokines [42], AP-1 may be one of the
putative transcription factors involved in the induction of
glutaminase expression. 
It has been reported that HSP60, present in the superna-
tant of total necrotic CNS cells, activates TLR4 on micro-Journal of Neuroinflammation 2008, 5:43 http://www.jneuroinflammation.com/content/5/1/43
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MyD88-dependent induction of neurotoxicity and glutaminase expression in microglia Figure 4
MyD88-dependent induction of neurotoxicity and glutaminase expression in microglia. (A) Neurotoxicity of MCM 
from wild type (WT) and MyD88-deficient microglia cultures either non-stimulated (MCM) or treated with necrotic HT22 
neurons (MCM (Nec.)). (B) RT-PCR analysis of glutaminase expression of wild type or MyD88-deficient microglia treated or 
not treated with necrotic HT22 neurons. (C) Analysis of L-Glutamic acid levels in MCM of microglial cell cultures. Results are 
shown as mean ± SD and are representative of at least two experiments. *** p < 0.001 and * p < 0.05.Journal of Neuroinflammation 2008, 5:43 http://www.jneuroinflammation.com/content/5/1/43
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glia leading to increased microglial neurotoxicity towards
cortical neurons. This effect could be partially but signifi-
cantly reduced by inhibiting iNOS activity, suggesting that
other neurotoxic mechanisms may be involved [43]. In
our study, iNOS was induced in microglia activated by
necrotic neurons but NO did not play a significant role in
mediating the killing of CGN. This probably reflects dif-
ferent susceptibilities to neurotoxic molecules on the part
of different neuronal cell populations. Of the variety of
neurotoxic molecules that activated microglia can secrete
[11], we clearly show that glutamate is the sole candidate
as the agent that enhances neurotoxicity of CGN through
NMDAR in microglia activated with necrotic neurons.
These results are in accordance with previously described
mechanisms of macrophage/microglial neurotoxicity [44-
46]. Moreover, it has been shown that excessive activation
of this receptor contributes to a large number of neurolog-
ical disorders associated with microglial activation
[47,48].
Conclusion
We demonstrate that necrotic neurons induce a pro-
inflammatory and glutaminase-mediated neurotoxic
response by microglia. Both mechanisms are dependent
on the adapter signalling protein MyD88 and may be
highly relevant to increased neuropathology in the con-
text of brain injury. Therefore, the MyD88-dependent
pathway and glutaminase activity may constitute poten-
tial targets for new pharmacological strategies to control
massive neuroinflammation and neurodegeneration.
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